classification of gastric and gastro-esophageal cancers based on expression of immunohistochemical markers
Not Applicable
- Conditions
- Health Condition 1: C16- Malignant neoplasm of stomach
- Registration Number
- CTRI/2021/04/032945
- Lead Sponsor
- IPSIT ILAHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Age > 18years
2)Biopsy proven primary adenocarcinoma of
the gastric and gastro-esophageal
junction
3)Willing to undergo staging
investigations
4)Consenting to participate in the study
Exclusion Criteria
1.Insufficient tissue sample for
immuno-histochemical study
2.Prior anti-cancer treatment
3.History of prior malignancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of various immunohistochemical markers (EBV, MSI, TP53) in gastric and GE junction tumors in North Indian patientsTimepoint: At the time of diagnosis
- Secondary Outcome Measures
Name Time Method Correlation of immuno-histochemical based classification of gastric and GE junction tumors with disease stageTimepoint: At the time of diagnosis